Neurorehabilitation Devices Market Size

Global Neurorehabilitation Devices Market Overview

Neurorehabilitation Devices Market Size was valued at USD 0.7 billion in 2021 and is projected to grow from USD 0.75 Billion in 2022 to USD 1.40 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.90% during the forecast period (2023 - 2032). Increased prevalence and incidence of neurological disorders are key drivers of growth, and demand for neurorehabilitation equipment is the key market drivers enhancing the market growth.Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Significant technological developments and the quickening rate of global population aging will both support market growth during the predicted period. Parkinson's disease and multiple sclerosis are two neurological disorders that are predicted to become more common, limiting patient movement and driving market growth. One of the main factors propelling market expansion is the rise in demand for neurorehabilitation equipment. The market for brain rehabilitation equipment is also growing as a result of the rapidly rising elderly population and the success of gaming systems in neural rehabilitation. Faster development will guarantee sustained industry growth over the foreseeable period.

It is anticipated that there will be a greater need for adequate and efficient neuro-rehab technologies and services. Some neurological conditions are either not currently treatable or incurable. Neurorehabilitation can help patients in these circumstances and restore their ability to carry out regular chores. These services have seen significant changes recently, which are anticipated to drive the market for neurorehabilitation devices to develop throughout the forecast period.  

Rising awareness about the benefits of neurorehabilitation devices, as well as the increasing incidence of neurological conditions like stroke, Parkinson's disease, multiple sclerosis, cerebral palsy, traumatic brain injury, and spinal cord injury, are all factors that contribute to the expansion of the neurorehabilitation market. The neurorehabilitation market is expanding due to a number of factors, including rising R&D spending and an increase in product approvals of neurorehabilitation devices from regulatory bodies.

February 2023: The pharmaceutical company Lupin plans to house a variety of neuro-rehabilitation services under one roof at its Atharv Ability center, marking the third services-related venture it has launched in just over a year. While reviewing the neurology field, a need gap was discovered due to patient outcomes and neurological illnesses' high rates of morbidity and disability. With a variety of rehabilitation programs for post-stroke patients, patients with traumatic brain injury, spinal cord injury, paediatric neurological conditions, Parkinson's, cerebral palsy, and multiple sclerosis, the multi-disciplined robotic and computer-assisted center may be the only one of its kind in India.

For example, in May 2023, the University of Calgary, in collaboration with Alberta Health Services, launched the Researching Strategies for Rehabilitation (RESTORE) Network, which will conduct clinical trials and new treatments to improve quality of life for people with neurological diseases.

For instance, in April 2023, Sensoria Health partnered with Padula Rehabilitation Technologies (PRT) and released NeurOpTrek – a cutting-edge wearable device that improves vision and helps reduce fall risk among the elderly who are prone to such health conditions.

For example, in February 2023, MindMaze introduced Izar, a completely new tool that has been recently made accessible to both United States as well as some European countries such as Switzerland, Germany and France. The aim of this device is to assist PD patients during their hand function assessment.

In addition to this, Neurofenix secured EUR7 million capital investment from UK investors, thus enabling it to extend its product line and start US-based testing in April 2022. Through the patient-centric approach taken by a company toward at-home rehabilitation programs that have proved more supportive and engaging than traditional alternatives.

Neurorehabilitation Devices Market Trends

• Rapid Technological Advances to boost market growth

During the forecast period, significant technology advancements and the rapid increase in the world's aging population will also contribute to market expansion. The prevalence of neurological conditions like Parkinson's disease and multiple sclerosis is expected to rise, restricting patient mobility, and fueling market expansion. Additionally, the market for brain rehabilitation devices is expanding due to the aging population's rapid increase and the effectiveness of gaming systems in neural rehabilitation. A faster rate of development will ensure that industry growth will be strong during the forecast period.

Increased rates of neurological illnesses, greater patient and care provider awareness, and an increase in the target patient population are the main drivers of the industry's expansion. ly, the senior population is growing, which has raised the frequency of age-related neurological illnesses and, in turn, the prevalence of movement impairments. The demand for adequate and effective neuro-rehab tools and services is expected to rise. Some neurological diseases cannot be fully cured or do not currently have effective treatments. In these situations, neurorehabilitation can save patients and enables them to perform daily tasks. In recent years, these services have seen major adjustments, which are expected to fuel the growth of the neurorehabilitation devices market during the forecast period.  

Recent studies from the WHO indicate that the number of those 65 and older is predicted to increase from 7% in 2000 to 16% in 2050. According to data released by the UN in 2012, there will be 1.13 billion older people worldwide by 2022. The aging population is more susceptible to age-related neurological diseases like Parkinson's disease as their immune systems are weaker. As a result, during the projected period, the market for neurorehabilitation devices will expand due to the growing base of an older population. The need for neurorehabilitation equipment is expected to rise in Asian nations like Japan, China, and India due to an aging population and significant untapped potential. The most frequent symptom of neurological disorders is immobility. Stroke is the largest cause of disability in the US and the fifth highest cause of death, according to the American Stroke Association. Multiple sclerosis affects about 2.5 million people worldwide, but Parkinson's disease affects 10 million. These factors are expected to widen the market CAGR across the globe in the recent years.

The utilization of electronic robotic and computer-aided apparatus has significantly altered neurorehabilitation in recent years. These tools help improve how well patients respond to therapeutic interventions for rehabilitation. The sector has great growth potential because neurological disorders are becoming more common. This is another factor driving the growth of the neurorehabilitation devices market revenue.

Neurorehabilitation Devices Market Segment Insights

Neurorehabilitation Devices Type Insights

The Neurorehabilitation Devices market segmentation, based on type, includes neuro-robotic devices, wearable medical devices, non-invasive stimulators, and brain-computer interfaces. The neuro-robotic devices held the majority share in 2021 contribution to around ~46%-47% in respect to the neurorehabilitation devices market revenue. To connect robotic devices with accurate biological simulations of the brain, neurorobotics blends robotics, neurosciences, and machine learning. Recent advancements greatly aid Neurorobotics in this area, such as exoskeletons and prosthetics. Due to their high availability and the manufacturers' growing efforts in developing innovative systems and platforms, these systems are anticipated to generate significant revenues during the forecast period.

July 2019:Ekso Bionics announced that they were expanding their medical exoskeletons by including an upper extremity rehabilitation device known as EksoUE. In January 2019, Ekso Bionics announced an agreement with Zhejiang Youchuang Venture Capital Investment Co. Ltd for establishing a joint venture for the development of a exoskeleton manufacturing center for capturing the exoskeleton market in China and other Asian countries.  

December 2018:Bionik Laboratories entered into a multi-year rental contract agreement with Kindred Hospital Rehabilitation Services (‘Kindred’) for multiple units of the company’s InMotion Arm Robotic system.

Neurorehabilitation Devices Application Insights

The neurorehabilitation devices market segmentation, based on application, includes brain stroke, Parkinson's disease, multiple sclerosis, spinal cord injury, cerebral palsy, and schizophrenia.  Brain strokes are expected to occupy the largest market share during the forecast period as the blood, and nutrient supply to the brain is cut off during a stroke, which can lead to the death of brain cells. They can cause motion impairment, sensory impairment, cognitive impairment, and visual impairment. Motion impairment is the most frequent defect connected to a stroke among these symptoms. Stroke was the top cause of disability and the second largest cause of death worldwide in 2013. An older population and those with lifestyle conditions are particularly vulnerable to this ailment. Due to the high incidence and prevalence of mobility problems as well as their primary cause, the market growth is the largest.

Neurorehabilitation Devices Type Insights

The neurorehabilitation devices market data has been bifurcated by rehabilitation centers, hospitals & clinics, and home care. Hospitals and clinics are expected to occupy the largest market share during the forecast period owing to the increased outflow of patients combined with the rising amount of services offered on the ground. Additionally, post the COVID-19 phase; consumers are focused on increasing spending on their health, which is expected to widen the segmental growth.    

June 2018:Bionik Laboratories Corp announced that they were entering into a rental contract agreement wit the Transistional Learning Center for InMotion Arm Robotic Systems. In May 2018, the company announced that they were entering into a rental agreement with Tallahassee Memorial HealthCare in Tallahassee, Florid. This is expected to boost the neurorehabilitation devices industry.

March 2023:Askham Village, a specialist supplier of rehabilitation services based in Cambridge, has partnered with virtual reality company Neuromersiv to test its most recent products, which are intended for immersive and engaging neurorehabilitation with patients recuperating from a stroke. In order to reestablish independent living, it will prioritize simulating practical duties including personal care, kitchen use, and bathroom use. The only neuro rehab VR system now available uses functional tasks carried out in simulated

Neurorehabilitation Devices Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific, and Rest of the World. North America Neurorehabilitation Devices market accounted for USD 6.3 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the increasing incidence rate of neurological diseases, the increasing geriatric population, and the sophisticated and equipped healthcare infrastructure.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3:  NEUROREHABILITATION DEVICES MARKET SHARE BY REGION 2021 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Neurorehabilitation Devices market is expected to grow in market share during the forecast period owing to the presence of prominent players in the region and the increased adoption rate of these services. An increased patient base with neurological disorders will also add to the regional growth. Further, the Germany Neurorehabilitation Devices market held the largest market share, and the UK Neurorehabilitation Devices market was the fastest growing market in the European region

The Asia-Pacific Neurorehabilitation Devices Market is expected to grow at the fastest CAGR from 2022 to 2030. Factors such as improving healthcare infrastructure, rising awareness of neurorehabilitation devices, and the increased expansion of prominent players in the region will account for a wider segmental growth of the region. Moreover, China Neurorehabilitation Devices market held the largest market share, and the India Neurorehabilitation Devices market was the fastest growing market in the Asia-Pacific region

For instance, India Neurorehabilitation Devices market is expected to grow significantly during the forecast period owing to expanded infrastructure within the region combined with rising disposable income. Additionally, various international players are setting up shop in India owing to the rising prevalence of neurological diseases and the rising number of geriatric populations, which will add to the regional growth.  

Neurorehabilitation Devices Key Market Players & Competitive Insights

Major market players are expected to invest heavily with their research and development departments to widen their consumer base and increase revenues for the neurorehabilitation devices market. Market leaders are focused on expanding their presence by participating in various development activities such as market developments including new product launches, mergers and acquisitions, increased investments, and collaboration with other organizations. Additionally, prominent leaders are focused on expanding the neurorehabilitation devices by offering their devices at a cost-effective nature.  

Another primary strategy that resides within the neurorehabilitation devices industry is by reducing operational costs and benefitting increased production. During the forecast period the neurorehabilitation devices industry is expected to cater a wider end-use vertical by offering products that come with increased functionalities and capabilities. The neurorehabilitation devices market major player such as Abbott Laboratories (US), Ekso Bionics Holdings Inc (US), Helius Medical Technologies (US), Hocoma AG (Switzerland) and others are working to increase their consumer base by introducing new products towards their portfolios.

High-quality product development and manufacture are Hocoma AG's goals while capturing a wider competitive base. Their products have a high level of safety and include a spectrum of user-friendliness that benefits both patients and therapists. Their products adhere to all applicable international standards and medical legislation. While working closely with its partners in research and sales, Hocoma tries to understand the needs of their customers by guaranteeing the security of their products.

Medtronic produces astonishing things by combining data, artificial intelligence, and their extensive understanding of the human body. They are focused on their manufacturing by using data-driven insights to improve care by customizing therapies in real-time significantly. Additionally, Medtronic is focused on providing the edge of technology advances patient care by reinventing robotic-assisted surgery to reach more patients with the highest levels of precision and predictability. They combine cutting-edge technology, a thorough understanding of the human body, and cutting-edge medical science to develop novel treatments.

Key Companies in the Neurorehabilitation Devices market includes

• Abbott Laboratories (US)


• Helius Medical Technologies (US)


• Hocoma AG (Switzerland)


• Ekso Bionics Holdings Inc (US)


• Medtronic, Inc (Ireland) among others

Neurorehabilitation Devices Industry Developments

June 2022: Spine X, Inc., a leader in clinical bioelectric medical device company, announced that they enrolled their first patient in a key study evaluating SCONE device. A critical study, known as the SCONE study, evaluates the safety and efficacy of SCONE devices for treating neurogenic bladders. This is the first major study for testing non-invasive spinal nerve regulation techniques for treating neurogenic bladder.

Neurorehabilitation Devices Market Segmentation

Neurorehabilitation Devices Type Outlook

• Neuro-Robotic Devices


• Wearable Medical Devices


• Non-Invasive Stimulators


• Brain-Computer Interfaces

Neurorehabilitation Devices Application Outlook

• Brain Stroke


• Parkinson’s Disease


• Multiple Sclerosis


• Spinal Cord Injury


• Cerebral Palsy


• Schizophrenia

Neurorehabilitation Devices End-User Outlook

• Rehabilitation Centers


• Hospitals & Clinics


• Home Care

Neurorehabilitation Devices Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America